{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P61073",
      "entity_text" : "CXCR4",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ02307",
      "entity_text" : "AMD70",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Novel CXCR4 antagonists, including the orally active AMD70, are currently in clinical trials for various indications.",
  "reading_complete" : "2020-08-03T11:29:09Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T11:23:49Z",
  "trigger" : "antagonists",
  "evidence" : [ "CXCR4 antagonists, including the orally active AMD70" ],
  "pmc_id" : "3563081",
  "score" : 0
}